February 5, 2013
peHUB Wire is a free daily newsletter delivered to your inbox. To enable us to keep providing this service free of charge to members of the private equity and venture capital community, we reserve the right to contact you with special invitations to sample or purchase private equity-related products. By submitting this free subscription request for peHUB Wire, you are also consenting to this communication. Should you ever wish to unsubscribe from a particular communication you may activate the unsubscribe mechanism at the bottom of the email. This will discontinue both the special invitations mentioned previously, as well as your subscription to the daily newsletter.
The information you provide will be safeguarded by Thomson Reuters, whose subsidiaries may use it to keep you informed of relevant products and services. We occasionally allow reputable companies outside Thomson Reuters to mail details of products which may be of interest to you. As an international group, we may transfer your data on a global basis for the purposes indicated above.
Should you have any questions please do not hesitate to contact us: email@example.com
peHUB First Read
peHUB Second Opinion
Entrepreneur-friendly deals continue in Q3
CVC-backed Asia Health Century plans $300 mln Hong Kong IPO – WSJ
VC-backed Boku buys India-based Qubecell
Iroko Pharmaceuticals to receive $75 mln from OrbiMed
Join the 4,711 members of peHUB to make connections, share your opinion, and follow your favorite authors. There are 1,184 readers logged in right now!
Join the Community